Forskning ved Københavns Universitet - Københavns Universitet

Forside

A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin

Publikation: Bidrag til tidsskriftTidsskriftartikel

  • Mansoor Raza Mirza
  • Bente Lund
  • Jacob Christian Lindegaard
  • Nina Keldsen
  • Anders Mellemgaard
  • René dePont Christensen
  • Kamma Bertelsen
Treatment of epithelial ovarian cancer patients relapsing with a short treatment-free interval (TFI) after prior chemotherapy is unsatisfactory. This phase II trial evaluated the activity and feasibility of pegylated liposomal doxorubicin (PLD) plus gemcitabine in this setting.
OriginalsprogEngelsk
TidsskriftJournal of Gynecologic Oncology Nursing
Vol/bind119
Udgave nummer1
Sider (fra-til)26-31
Antal sider6
ISSN1536-9935
DOI
StatusUdgivet - 1 okt. 2010

ID: 34096319